• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT? PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT? PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911608300
Device Problem Occlusion Within Device (1423)
Patient Problems Angina (1710); Atherosclerosis (1728); Chest Pain (1776); Dyspnea (1816); Reocclusion (1985)
Event Date 05/04/2015
Event Type  Injury  
Event Description
Same case as mdr id: 2134265-2015-02008 and 2134265-2015-02009.(b)(4) clinical study.It was reported that angina, atherosclerosis and in-stent restenosis (isr) occurred.In (b)(6) 2012, the patient presented due to unstable angina.Following day, the coronary angiography and index procedure were performed respectively.The target lesion was located in first obtuse marginal (om1) with 90% in-stent restenosis and was 6.0 mm long with a reference vessel diameter of 3.00 mm.The lesion was treated with direct stent placement using a 3.00 x 8.00 mm promus element¿ plus stent, resulting with 0% residual stenosis.One day post procedure, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2014, the 2.25 x 16 mm promus premier¿ stent was implanted in the om1.In (b)(6) 2014, the 2.5 x 16 mm promus element plus stent was implanted in the middle of left circumflex (lcx).In (b)(6) 2015, the patient presented with one week history of recurrent chest and mid-back discomfort.The coronary angiography revealed 80% mid stenosis isr of 2.5 x 16 mm promus element plus stent, 80% stenosis om1 isr of study stent as well as the 2.25 x 16 mm promus premier¿ stent.Subsequently, the om1 was treated with balloon angioplasty, resulting with 0% residual stenosis.Additionally, the stenosis in distal lcx was treated with balloon angioplasty with 20% residual stenosis.Also, stenosis in the right posterolateral (rpl) branch was treated with balloon angioplasty with 0% residual stenosis.One day post procedure, the event was considered resolved and the patient was discharged on aspirin and clopidogrel.
 
Manufacturer Narrative
Device is a combination product.The complaint device was not returned for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The root cause is anticipated procedural complications as this event is a known physiological effect of the procedure and is noted within the dfu.(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that in (b)(6) 2015, the patient presented emergently due to chest pain and shortness of breath (sob).Subsequently, coronary angiography revealed 90% in-stent restenosis (isr) of 2.5 x 16 mm promus premier⠓tent (commercial product) in distal portion; 80% isr of study stent and of 2.25 mm promus premier stent (commercial product) in om1.The 90% isr in distal left circumflex (lcx) was treated with direct stent placement using a 2.5mm x 20mm promus drug-eluting stent, resulting to 0% residual stenosis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT? PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key4667955
MDR Text Key5729038
Report Number2134265-2015-02007
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/19/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/21/2012
Device Model NumberH7493911608300
Device Catalogue Number39116-0830
Device Lot Number14987604
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/07/2015
Initial Date FDA Received04/08/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received06/04/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/17/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age63 YR
-
-